Results 31 to 40 of about 6,020,192 (375)

Boosting multiple sclerosis lesion segmentation through attention mechanism [PDF]

open access: yes, 2023
Magnetic resonance imaging is a fundamental tool to reach a diagnosis of multiple sclerosis and monitoring its progression. Although several attempts have been made to segment multiple sclerosis lesions using artificial intelligence, fully automated analysis is not yet available.
arxiv   +1 more source

Gut Microbiome in Progressive Multiple Sclerosis

open access: yesAnnals of Neurology, 2021
This study was undertaken to investigate the gut microbiome in progressive multiple sclerosis (MS) and how it relates to clinical disease.
Laura M. Cox   +17 more
semanticscholar   +1 more source

RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice

open access: yesJournal of Neuroinflammation, 2020
Background Targeting RNA polymerase-1 (POL1) machinery is a new strategy for suppression of multiple sclerosis (MS) relapse activity. Oral administration of POL1 inhibitor RAM-589.555, which is characterized by high permeability and bioavailability in ...
Rina Zilkha-Falb   +4 more
doaj   +1 more source

Digital Twins for Multiple Sclerosis

open access: yesFrontiers in Immunology, 2021
An individualized innovative disease management is of great importance for people with multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional disease.
Isabel Voigt   +5 more
semanticscholar   +1 more source

“I need personal experiences or some sort of documentation”: a qualitative study on where people with multiple sclerosis seek information on dietary and herbal supplements

open access: yesBMC Complementary Medicine and Therapies, 2021
Background The use of dietary and herbal supplements (DIHES) is widespread among people with multiple sclerosis (PwMS). PwMS are a highly informed patient group, and they use several types of sources to seek information on subjects related to their ...
Sofie Bergien   +4 more
doaj   +1 more source

Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple Sclerosis

open access: yesVaccines, 2023
Vaccines against the SARS-CoV-2 virus were authorized for use by the Food and Drug Administration (FDA) in the United States and have proven effective for the prevention of morbidity and death from COVID-19.
Luke B. Elias   +5 more
doaj   +1 more source

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

open access: yesAnnals of Neurology, 2011
New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system lesions in space and time has been simplified, and in ...
C. Polman   +17 more
semanticscholar   +1 more source

The potential of serum neurofilament as biomarker for multiple sclerosis

open access: yesBrain : a journal of neurology, 2021
Multiple sclerosis is a highly heterogeneous disease, and the detection of neuroaxonal damage as well as its quantification is a critical step for patients.
S. Bittner   +4 more
semanticscholar   +1 more source

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

open access: yesTherapeutic Advances in Neurological Disorders, 2021
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage.
H. Wiendl   +44 more
semanticscholar   +1 more source

Standard versus innovative robotic balance assessment for people with multiple sclerosis: a correlational study

open access: yesEuropean Journal of Medical Research, 2023
Introduction Balance disorders are common in people with Multiple Sclerosis (PwMS) and, together with other impairments and disabilities, often prevent PwMS from performing their daily living activities.
Jessica Podda   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy